1. Home
  2. PTCT vs HLNE Comparison

PTCT vs HLNE Comparison

Compare PTCT & HLNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PTC Therapeutics Inc.

PTCT

PTC Therapeutics Inc.

HOLD

Current Price

$76.81

Market Cap

5.3B

Sector

Health Care

ML Signal

HOLD

Logo Hamilton Lane Incorporated

HLNE

Hamilton Lane Incorporated

HOLD

Current Price

$146.63

Market Cap

6.1B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
PTCT
HLNE
Founded
1998
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
5.3B
6.1B
IPO Year
2013
2017

Fundamental Metrics

Financial Performance
Metric
PTCT
HLNE
Price
$76.81
$146.63
Analyst Decision
Buy
Buy
Analyst Count
17
9
Target Price
$73.76
$160.89
AVG Volume (30 Days)
1.2M
536.0K
Earning Date
02-26-2026
02-03-2026
Dividend Yield
N/A
1.49%
EPS Growth
N/A
19.80
EPS
8.94
5.55
Revenue
$1,779,150,000.00
$733,070,000.00
Revenue This Year
$127.32
$8.51
Revenue Next Year
N/A
$20.20
P/E Ratio
$8.64
$26.15
Revenue Growth
97.54
13.01
52 Week Low
$35.95
$111.98
52 Week High
$87.50
$179.19

Technical Indicators

Market Signals
Indicator
PTCT
HLNE
Relative Strength Index (RSI) 52.19 70.59
Support Level $74.22 $143.45
Resistance Level $79.10 $149.01
Average True Range (ATR) 2.12 3.83
MACD -0.16 0.89
Stochastic Oscillator 50.16 83.26

Price Performance

Historical Comparison
PTCT
HLNE

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.

About HLNE Hamilton Lane Incorporated

Hamilton Lane Inc is a private markets investment firm globally, providing solutions to institutional and private wealth investors around the world. Dedicated exclusively to private markets investing for more than 30 years, the firm currently employs approximately 750 professionals operating in offices throughout North America, Europe, Asia Pacific, and the Middle East. It has approximately $986 billion in assets under management and supervision, composed of nearly $141 billion in discretionary assets and more than $845 billion in non-discretionary assets. The group specializes in building flexible investment programs that provide clients access to the full spectrum of private markets strategies, sectors, and geographies.

Share on Social Networks: